MFSD11

Across TCGA pan-cancer cohorts, MFSD11 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated MFSD11 data layer compared with 22 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MFSD11 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MFSD11 expression acts as an unfavorable survival marker.

COAD, LIHC, and SKCM are the cancer types where MFSD11 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	III,IV	0.054	0.793	<.001	12	view →
LIHC	DFS	Median	All	0.145	0.558	.001	9	view →
SKCM	DFS	Median	III,IV	0.087	0.647	.013	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

MFSD11–COAD (OS)

Open the COAD breakdown →